Legislation that would provide four years of temporary Medicare coverage for medical devices designated by the FDA as breakthrough devices was advanced through a June 27 vote by the House Ways and Means Committee, which sent the bill to the House floor for consideration. The proposed Ensuring Patient Access to Critical Breakthrough Products Act of 2023, H.R. 1691, which was i... Read More